Disseminated tumor cells and dormancy in prostate cancer metastasis
Open Access
- 1 August 2016
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 40, 9-15
Abstract
No abstract availableKeywords
Funding Information
- National Cancer Institute
This publication has 34 references indexed in Scilit:
- Influence of zoledronic acid on disseminated tumor cells in bone marrow and survival: results of a prospective clinical trialBMC Cancer, 2013
- GAS6 Receptor Status Is Associated with Dormancy and Bone Metastatic Tumor FormationPLOS ONE, 2013
- In Vitro and In Vivo Prostate Cancer Metastasis and Chemoresistance Can Be Modulated by Expression of either CD44 or CD147PLOS ONE, 2012
- Hypoxia Stabilizes GAS6/Axl Signaling in Metastatic Prostate CancerMolecular Cancer Research, 2012
- The prostate cancer bone marrow niche: more than just ‘fertile soil’Asian Journal of Andrology, 2012
- VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast ProgenitorsCancer Cell, 2011
- Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in boneJournal of Experimental Medicine, 2011
- Homing of Cancer Cells to the BoneCancer Microenvironment, 2011
- Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrowJournal of Clinical Investigation, 2011
- Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical RecurrenceClinical Cancer Research, 2009